Buckland Partners Management Co’s Centessa Pharmaceuticals CNTA Stock Holding History

Buckland Partners Management Co’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,000	Closed	-$1.19M	–	99
2026 Q1	$1.19M	Buy	+30,000	New	+$767K	0.72%	44

Buckland Partners Management Co's CNTA Position: Q2 2026 in Review

Buckland Partners Management Co sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 30,000 shares — an estimated $1.19M sold.

Buckland Partners Management Co first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $1.19M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Buckland Partners Management Co reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Buckland Partners Management Co sold 30,000 Centessa Pharmaceuticals shares in Q2 2026, an estimated $1.19M.
Buckland Partners Management Co first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Buckland Partners Management Co's Centessa Pharmaceuticals position peaked at $1.19M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Buckland Partners Management Co's 13F filing for Q2 2026, filed 7 Aug 2026.